Prophylaxie médicamenteuse de la maladie veineuse thromboembolique en soins palliatifs

Key points Venous thromboembolism incidence as identification of bleeding risk factors is not well defined in patients admitted to palliative units . There is no randomized controlled trial evaluating medical thromboprophylaxis in patients admitted to palliative units . Medical thromboprophylaxis seems to be inappropriate in patients admitted to palliative units . Medical thromboprophylaxis prescription should be discussed individually in patients admitted to palliative units . Conversely, cancer patients admitted for an acute medical disease should receive medical thromboprophylaxis, if their prognosis exceeds several months .